Search…

MeiraGTx (MGTX.US) reached a collaboration on gene therapy with LLY.US, and saw a big surge in pre-market trading.

10/11/2025

According to the Securities Times app, the stock price of gene therapy company MeiraGTx Holdings (MGTX.US) rose 13.22% in pre-market trading on Monday. Prior to this, the company announced a broad strategic partnership with Eli Lilly (LLY.US) to jointly develop and commercialize gene therapies for ocular diseases.

Latest

6 m ago

American stock market long-term optimist Ed Yardeni warned that the current rally is overly crowded and susceptible to pullbacks, pointing out that there is a risk in holding large-cap artificial intelligence stocks like NVIDIA when the path of the Federal Reserve policy is still uncertain.

6 m ago

Douyin's response to "selling Maotai below market price will be fined": the rumors are not true, it is a misunderstanding.

7 m ago

Santander Bank hires Citi Group and Goldman Sachs to reduce their stake in their Polish subsidiary by 13%.

7 m ago

After Novo Nordisk withdrew from concerns over regulatory risks, Pfizer announced a deal to acquire the obesity drug developer Metsera for over 100 billion US dollars, which will enable Pfizer to re-enter the weight loss drug market. In early trading on Monday, Pfizer rose by 0.8% and Novo Nordisk by 1.2% on the US stock market.

9 m ago

The Federal Housing Finance Agency of the United States stated that it is studying a 50-year mortgage scheme to increase the affordability of housing prices. Comparing data cited by Fannie Mae and Freddie Mac shows that monthly payments for American home buyers have decreased, but the repayment period has been significantly extended.

See all latest